Related Experiment Video
Updated: Jan 16, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Diabetes Phenotypes in Patients Presenting a Myocardial Infarction: Progress Towards Precision Medicine?
Christelle Lacqua1, Arnaud Barbou1, Marianne Zeller2
1Department of Pharmacy, CHU Dijon Bourgogne, 21000 Dijon, France.
New patient profiles for type 2 diabetes at myocardial infarction reveal distinct groups, including severe insulin deficiency and age-related forms. Lower kidney function independently predicts worse cardiovascular outcomes within one year.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Traditional type 2 diabetes classification and management lack personalization.
- Myocardial infarction (MI) in diabetic patients requires better risk stratification.
- Understanding diabetes phenotypes at MI is crucial for personalized care.
Purpose of the Study:
- To identify distinct patient profiles of type 2 diabetes (T2D) at the time of myocardial infarction (MI).
- To assess 1-year cardiovascular event-free survival based on identified T2D profiles.
- To determine predictors of cardiovascular events in T2D patients experiencing MI.
Main Methods:
- Retrospective study of 250 T2D patients admitted for MI.
- K-means cluster analysis using age at diagnosis, BMI, HbA1c, GAD antibodies, insulin resistance, and beta-cell function.
- Cox multivariate models to identify predictors of 1-year cardiovascular and major adverse cardiovascular events.
Main Results:
- Identified five T2D profiles: severe insulin-deficient (46%), severe insulin-resistant (3%), mild obesity-related (16%), mild age-related (33%), and severe autoimmune (2%).
- Severe insulin-deficient and mild age-related diabetes were frequent phenotypes at MI.
- Higher glomerular filtration rate was the sole independent predictor of longer cardiovascular event-free survival (HR 0.97) and MACE-free survival (HR 0.98).
Conclusions:
- Distinct T2D pathophysiological phenotypes exist at the time of MI, notably severe insulin-deficient and mild age-related.
- These phenotypes can be estimated using clinical and biochemical markers.
- Low glomerular function rate is a significant risk factor for adverse cardiovascular outcomes post-MI in T2D patients.
Related Concept Videos
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cardiomyopathy II: Dilated Cardiomyopathy

